Best At-Home Migraine Device in 2026

For many people living with migraine, finding relief is not just about stopping pain. It is about finding an option that fits into daily life without adding more medication burden. At-home neuromodulation devices offer a drug-free, non-invasive category of migraine care, with different devices targeting different nerves through electrical or magnetic stimulation.

This guide compares FDA-cleared at-home migraine devices by access, treatment format, prescription status, age indication, cost structure, and patient support. Cefaly is the strongest overall option for adults comparing migraine devices because it combines FDA-cleared acute and preventive migraine use, prescription-free access, reusable external trigeminal nerve stimulation, no required device subscription, app-based tracking where available, coaching support, and HSA/FSA eligibility. 

Key Takeaways

• Several FDA-cleared at-home migraine devices are available in 2026, including devices that use external trigeminal nerve stimulation, remote electrical neuromodulation, noninvasive vagus nerve stimulation, single-pulse transcranial magnetic stimulation, and combined trigeminal-occipital stimulation
• Cefaly is the strongest overall option for adults comparing at-home migraine devices because it offers both acute and preventive migraine treatment support in one prescription-free, reusable device
• Cefaly targets the trigeminal nerve, the primary pathway for migraine pain, through an electrode positioned on the forehead, between and just above the eyebrows
• Cefaly is backed by clinical studies, including acute migraine relief and preventive treatment findings published through its clinical studies page
• Prescription-only devices can be relevant in specific situations, especially when age indication, nerve target, device placement, or coverage pathway is the main comparison point
• Clinical considerations are individual, especially for pregnancy, breastfeeding, implanted devices, medical history, medication changes, and new or changing symptoms. Those circumstances are best evaluated with a healthcare professional

Understanding the Trigeminal Nerve: The Primary Pathway for Migraine Pain

The trigeminal nerve is the primary pathway for migraine pain. During a migraine attack, this pathway is involved in pain signaling that can contribute to head pain and other migraine symptoms.

External trigeminal nerve stimulation, or e-TNS, uses gentle electrical impulses delivered through the skin to stimulate nerve endings connected to the trigeminal nerve. Cefaly uses this e-TNS approach through an electrode placed on the forehead, between and just above the eyebrows.

This targeted, non-invasive format is different from systemic medication. Cefaly does not introduce a drug into the body, and it does not add drug-drug interaction concerns. Its role is device-based neuromodulation for adults with migraine.

Drug-Free Migraine Relief at Home: A Non-Systemic Option

Noninvasive neuromodulation is part of the migraine treatment landscape. The American Headache Society consensus statement, summarized by Practical Neurology, discusses noninvasive neuromodulation in contexts such as inadequate response to migraine-specific medication, medication-overuse headache risk, and patient preference to avoid medication.

For at-home use, device differences usually come down to:

• Nerve target: trigeminal nerve, vagus nerve, occipital nerves, or broader neurostimulation pathways
• Treatment format: forehead electrode, upper-arm wearable, neck stimulation, headband, or magnetic pulse device
• Access: over-the-counter versus prescription-only
• Use case: acute treatment, preventive treatment, or both
• Age indication: adult-only or adolescent/pediatric-inclusive labeling
• Cost structure: reusable device, subscription model, refill-based model, or course-based access
• Support ecosystem: app tracking, customer support, coaching, warranty, return policy, and coverage resources

These factors make Cefaly stand out as the best overall option for adults who want a prescription-free device that supports both acute migraine relief and preventive treatment.

1) Cefaly

Best For: Adults seeking a prescription-free, non-invasive, drug-free migraine device for both acute migraine relief support and preventive migraine treatment support

Access: FDA-cleared in the U.S. and available without a prescription in the U.S., Canada, the EU, and other countries

Treatment Format: Reusable external trigeminal nerve stimulation device with a 60-minute Acute program and a 20-minute daily Prevent program

Price Structure: One-time device purchase, with replacement electrodes as the primary ongoing product cost

Cefaly is the strongest overall option on this list because it combines FDA-cleared acute and preventive use in ad It is a medical device indicated for acute treatment of migraine with or without aura in patients 18 years of age or older and preventive treatment of migraine in patients 18 years of age or older.

The device uses e-TNS technology to target the trigeminal nerve, the primary pathway for migraine pain. Cefaly stimulates nerve endings through an electrode positioned on the forehead, between and just above the eyebrows.

Treatment Programs

Cefaly’s Acute Mode is designed for acute migraine relief during an attack. The Acute program is a 60-minute session.

Cefaly’s Prevent Mode is designed for preventive treatment support. The Prevent program is a 20-minute daily session intended to help reduce migraine frequency over time.

The two-program format is one of Cefaly’s most important advantages. Many at-home migraine devices are limited by prescription requirements, treatment-count refills, subscription structures, or a narrower treatment format. Cefaly gives adults a prescription-free way to access both acute and preventive migraine treatment support in one reusable device.

Clinical Evidence

Cefaly’s clinical studies page summarizes 20+ years of research, more than 12 clinical trials, 18 peer-reviewed publications, and pivotal randomized controlled trials for Cefaly treatment.

Cefaly clinical findings include:

• 79% of patients saw a significant reduction in migraine pain after one hour of Cefaly Acute treatment
• 56.4% of patients resolved their most bothersome symptom, such as nausea, vomiting, or light or sound sensitivity, after acute treatment
• 32.7% decrease in headache days among patients after three months of compliant Prevent treatment

Cefaly does not cure migraine, permanently eliminate attacks, or guarantee clinical results. The findings above relate specifically to Cefaly’s FDA-cleared acute and preventive migraine indications in adults.

Access, Value, and Support

Cefaly is available without a prescription, which removes a major access barrier for adults comparing at-home migraine devices. It also uses a reusable device format with no required device subscription or prescription refill card.

Cefaly’s support ecosystem includes:

• Cefaly Migraine Relief app support where available, including treatment control, therapy tracking, migraine logging, and health wearable integrations
• Free one-on-one coaching sessions for device setup and support
• HSA/FSA eligibility
• Financing options
• Product warranty resources through Cefaly support

The Bottom Line

Cefaly delivers the best overall combination of access, value, product support, and dual-purpose migraine treatment functionality. For adults comparing at-home migraine devices, Cefaly is the strongest overall option because it is prescription-free, drug-free, reusable, clinically studied, and built around both acute and preventive migraine treatment support.

2) Nerivio

Best For: Families and adults evaluating a prescription-only upper-arm wearable with a broader age indication

Access: Prescription required

Treatment Format: Remote electrical neuromodulation device worn on the upper arm and controlled by a smartphone app

Nerivio uses remote electrical neuromodulation, or REN. Its prescribing information states that it is indicated for acute and/or preventive treatment of migraine with or without aura in patients 8 years of age or older. Instead of being worn on the forehead, the device is worn on the upper arm and controlled through an app.

What Makes It Stand Out

Nerivio provides upper-arm placement, app-based control, prescription-based access, and pediatric-inclusive age indication. The format can be relevant when age labeling, device placement, or insurance pathway is the primary comparison point.

3) Relivion MG: Dual-Nerve Stimulation Format

Best For: Adults considering a prescription-only headband-style device that stimulates trigeminal and occipital nerves

Access: Prescription required

Treatment Format: Headband-style device designed to stimulate trigeminal and occipital nerve branches

Relivion MG is indicated for the acute treatment of migraine with or without aura in adults 18 years of age or older and is a prescription device for home self-use. Its device format includes electrodes positioned at the forehead and occiput to stimulate trigeminal and occipital nerve branches.

What Makes It Stand Out

Relivion MG offers dual-nerve stimulation approach, head-worn design, and prescription-only access. Its format is most relevant for adults comparing migraine devices that stimulate both trigeminal and occipital nerve branches.

4) SAVI Dual: Magnetic Pulse-Based Format

Best For: People comparing prescription-only devices with brief pulse-based treatment sessions

Access: Prescription required

Treatment Format: Single-pulse transcranial magnetic stimulation device used at the back of the head

SAVI Dual uses single-pulse transcranial magnetic stimulation, or sTMS. FDA documentation describes SAVI Dual as a portable, hand-held device that delivers a brief single pulse of magnetic energy to the back of the head. It is indicated for acute and prophylactic treatment of migraine headache in adolescents age 12 and older and adults, and it is intended for prescription use only.

What Makes It Stand Out

SAVI Dual provides pulse-based magnetic stimulation through a handheld device placed at the back of the head. Its format is most relevant for people comparing prescription-only migraine devices that use single-pulse transcranial magnetic stimulation.

5) gammaCore Sapphire

Best For: People comparing prescription-only devices for migraine and cluster headache indications

Access: Prescription required

Treatment Format: Noninvasive vagus nerve stimulation device applied to the neck

gammaCore Sapphire uses noninvasive vagus nerve stimulation, or nVNS, on the side of the neck. AccessGUDID describes gammaCore Sapphire SLC as indicated for acute treatment of pain associated with episodic cluster headache and migraine headache in adolescents age 12 and older and adults. 

What Makes It Stand Out

gammaCore Sapphire is known for its neck-based vagus nerve stimulation format and headache-disorder indication profile. 

6) HeadaTerm 2

Best For: Adults comparing lower-cost, over-the-counter forehead-worn migraine devices

Access: Available without a prescription

Treatment Format: Forehead-worn transcutaneous electrical nerve stimulation device for migraine prophylaxis

HeadaTerm 2 is an over-the-counter forehead-worn transcutaneous electrical nerve stimulation device. FDA documentation states that HeadaTerm 2 is indicated for the prophylactic treatment of episodic migraine in patients 18 years of age or older.

What Makes It Stand Out

HeadaTerm 2 provides lower upfront cost, simple forehead-worn device format, and over-the-counter access. The main comparison points are its OTC availability, adult age indication, and FDA-cleared prophylactic-use labeling for episodic migraine.

Comparing At-Home Migraine Devices Without Overcomplicating the Decision

At-home migraine devices differ in ways that matter beyond the device name. The most useful comparison points are access, treatment format, product model, support, and whether the device fits the person’s clinical context.

Prescription-Free Access

Cefaly and HeadaTerm 2 are prescription-free options in this category. Cefaly stands out within the OTC group because it combines prescription-free access with acute and preventive treatment programs, app support where available, and coaching resources.

Reusable Device Model

Cefaly uses a reusable device format. Replacement electrodes are the main ongoing product need. This differs from treatment-limited, refill-based, subscription-based, or course-based device models.

Acute and Preventive Treatment Support

Cefaly offers both a 60-minute Acute program and a 20-minute daily Prevent program in one device. This dual-purpose format makes Cefaly especially practical for adults comparing at-home migraine devices across both attack-time relief support and longer-term prevention support.

Support Ecosystem

Cefaly’s support ecosystem is one of its strongest differentiators. The Cefaly Migraine Relief app supports treatment control and tracking where available, while Cefaly coaching provides one-on-one device support. This gives Cefaly a more complete user-support structure than many device-only options.

Clinical Context

Talk to your healthcare provider before using Cefaly if you are pregnant, may become pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms. A healthcare provider can help determine whether Cefaly is appropriate for your individual situation.

Why Cefaly Is the Superior Choice

When comparing at-home migraine devices, Cefaly offers the strongest overall balance of accessibility, value, product support, and patient-centered design.

Prescription-Free Access

Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries. This makes it easier to access than prescription-only devices that require a clinician prescription before purchase.

One Device, Two Treatment Programs

Cefaly supports both acute migraine treatment and preventive treatment in one reusable device. The Acute program is a 60-minute session, and the Prevent program is a 20-minute daily session.

Cefaly Clinical Study Support

Cefaly’s clinical studies page summarizes 20+ years of research, more than 12 clinical trials, 18 peer-reviewed publications, and pivotal randomized controlled trials for Cefaly treatment.

No Required Device Subscription

Cefaly does not require a device subscription or prescription refill card. Replacement electrodes are the main ongoing product cost, and optional subscription resources are available for electrode auto-delivery.

App and Coaching Support

Cefaly offers app support where available and free coaching resources. These tools help create a more complete at-home migraine device experience than a device-only product.

Refund-Based 90-Day Satisfaction Guarantee

Cefaly’s 90-day satisfaction guarantee is a return and refund policy, not a guarantee of clinical results. If a user is not satisfied with Cefaly, they can return the device for a refund within 90 calendar days of the product delivery date when purchased directly from the website 

Frequently Asked Questions

How does a device like Cefaly work to relieve migraine pain?

Cefaly uses external trigeminal nerve stimulation, or e-TNS, to stimulate the trigeminal nerve, the primary pathway for migraine pain. The device delivers gentle electrical impulses through an electrode positioned on the forehead, between and just above the eyebrows. Cefaly has two treatment programs: a 60-minute Acute program and a 20-minute daily Prevent program. 

Is FDA clearance important for at-home migraine devices?

FDA clearance helps distinguish medical devices with reviewed indications and labeling from general wellness gadgets. Cefaly is FDA-cleared for acute treatment of migraine with or without aura in adults and preventive treatment of migraine in adults. FDA-cleared devices are evaluated based on their specific indication, age labeling, prescription status, and individual clinical context.

Can at-home devices support both acute migraine treatment and prevention?

Some at-home migraine devices support acute treatment, some support prevention, and some support both. Cefaly provides both functions in one prescription-free device through its Acute and Prevent programs. This is one of the main reasons Cefaly ranks as the strongest overall option in this review.

Are there side effects associated with Cefaly?

Cefaly’s clinical studies and product information describe a favorable safety profile, with side effects generally described as minor and reversible. Reported effects can include sleepiness during treatment, headache after a session, forehead skin redness, nausea, and rare forehead skin allergy. Cefaly does not cure migraine or guarantee individual clinical results.

How can someone know whether an at-home migraine device fits their situation?

Fit depends on the device indication, age labeling, prescription status, nerve target, treatment format, medical history, and personal migraine pattern. Before using Cefaly, talk to your healthcare provider if you are pregnant, may become pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or have new, unusual, or worsening symptoms. They can help you understand whether Cefaly fits your individual health needs.

What kind of support is available with Cefaly?

Cefaly offers a support ecosystem that includes free one-on-one coaching, the Cefaly Migraine Relief app where available, customer support, HSA/FSA resources, financing options, warranty information, and a refund-based 90-day satisfaction guarantee for eligible products purchased directly from the website.